outcome of the Board Meeting under Regulation 30 read with 33 (3) of SEBI (LODR) Regulation 2015
Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Vista Pharmaceuticals Ltd. on 6ix
Earlier from Vista Pharmaceuticals
- Vista Pharmaceuticals Ltd. Press Release Nov 07 2024
- Board Meeting Intimation for For Approval Of Unaudited Financial Results For The Quarter Ended 30.09.2024
Later from Vista Pharmaceuticals
- Intimation Under Regulation 30 Of SEBI (Listing Obligations AndDisclosure Requirements) Regulations, 2015 - ''Issue Of World Health Organisation (WHO) G.M.P. Certificate.
- Vista Pharmaceuticals Ltd. Press Release Nov 14 2024
- Closure of Trading Window
- Vista Pharmaceuticals Ltd. Press Release Dec 29 2024
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Follow Vista Pharmaceuticals into a list and get an email when it puts out news.
Follow Vista Pharmaceuticals